Welcome to LookChem.com Sign In|Join Free
  • or
1-Piperidinecarboxylic acid, 4-[[4-chloro-2-(hydroxymethyl)phenyl]amino]-, 1,1-dimethylethyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

612545-92-3

Post Buying Request

612545-92-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

612545-92-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 612545-92-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,1,2,5,4 and 5 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 612545-92:
(8*6)+(7*1)+(6*2)+(5*5)+(4*4)+(3*5)+(2*9)+(1*2)=143
143 % 10 = 3
So 612545-92-3 is a valid CAS Registry Number.

612545-92-3Relevant academic research and scientific papers

Synthesis of new benzoxazinone derivatives as neuropeptide Y5 antagonists for the treatment of obesity

Torrens, Antoni,Mas, Josep,Port, Adriana,Castrillo, José Aurelio,Sanfeliu, Olga,Guitart, Xavier,Dordal, Alberto,Romero, Gonzalo,Fisas, Ma. Angeles,Sánchez, Elisabeth,Hernández, Enrique,Pérez, Pilar,Pérez, Raquel,Buschmann, Helmut

, p. 2080 - 2092 (2007/10/03)

Screening of our internal chemical collection against the neuropeptide Y5 (NPY Y5) receptor allowed the identification of a benzoxazine derivative 5f as a hit that showed moderate affinity (IC50 = 300 nM). With the aim of improving the in vitro potency, a series of 2-benzoxazinone derivatives have been synthesized and tested for NPY Y5 activity. Most of the compounds were found to be potent and selective NPY Y5 antagonists having nanomolar binding affinities for the NPY Y5 receptor and showing functional antagonism in the forskolin-induced cyclic AMP test. Prelimminary studies in order to understand the structure-activity relationship were undertaken. Selected compounds were further evaluated for in vivo efficacy, affording the lead compound 2-[4-(8-methyl-2-oxo-4H-benzo[d][1,3]oxazin-1-yl)piperidin-1-yl] -N-(9-oxo-9H-fluoren-3-yl)acetamide 5p, which displayed in vivo activity reducing food intake in rodents.

BENZOXAZINONE-DERIVED SULFONAMIDE COMPOUNDS, THEIR PREPARATION AND USE AS MEDICAMENTS

-

Page/Page column 168-169, (2008/06/13)

The present invention relates to benzoxazinone-derived sulphonamide compounds of general formula (I), a process for their preparation, a medicament comprising these compounds and the use of benzoxazinone-derived sulphonamide compounds for the preparation

ACTIVE SUBSTANCE COMBINATION COMPRISING A COMPOUND WITH NPY RECEPTOR AFFINITY AND A COMPOUND WITH 5-HT6 RECEPTOR AFFINITY

-

Page/Page column 281; 329-330, (2010/02/10)

The present invention relates to an active substance combination comprising at least one compound with neuropeptide Y-receptor affinity and at least one compound with 5-HT6 receptor affinity, a medicament comprising said active substance combination, and

Benzoxazinone-derived compounds, their preparation and use as medicaments

-

Page/Page column 18, (2008/06/13)

The present invention relates to Benzoxazinone-derived compounds of general formula (I), methods for their preparation, medicaments comprising these compounds as well as their use for the preparation of a medicament for the treatment of humans or animals.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 612545-92-3